Matsuda Masaru bought ARQT
November 4, 2026 · Form 4 insider transaction
Matsuda Masaru bought 40,000 shares of Arcutis Biotherapeutics, Inc. at $3.64 per share, a transaction worth $145.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$3.64
Total value
$145.6K
InsiderMatsuda Masaru
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 4, 2026
Filing dateNovember 4, 2026
Shares owned after151,289
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on June 5, 2026, by the Reporting Person, with a plan end date of September 1, 2027.